Cholesterol-lowering gene therapy prevents HFpEF in obese type 2 diabetic mice

被引:0
|
作者
Aboumsallem, J. P. [1 ]
Muthuramu, I. [1 ]
Mishra, M. [1 ]
De Geest, B. [1 ]
机构
[1] Katholieke Univ Leuven, Dept Cardiovasc Sci, Leuven, Belgium
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P635
引用
收藏
页码:165 / 165
页数:1
相关论文
共 50 条
  • [1] Cholesterol-Lowering Gene Therapy Prevents Heart Failure with Preserved Ejection Fraction in Obese Type 2 Diabetic Mice
    Aboumsallem, Joseph Pierre
    Muthuramu, Ilayaraja
    Mishra, Mudit
    De Geest, Bart
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (09)
  • [2] CHOLESTEROL-LOWERING THERAPY MAY RETARD THE PROGRESSION OF DIABETIC NEPHROPATHY
    LAM, KSL
    CHENG, IKP
    JANUS, ED
    PANG, RWC
    [J]. DIABETOLOGIA, 1995, 38 (05) : 604 - 609
  • [4] Cholesterol-lowering therapy may retard the progression of diabetic nephropathy
    Parving, HH
    [J]. DIABETOLOGIA, 1996, 39 (03) : 367 - 367
  • [5] Cholesterol-lowering therapy for smokers
    Jackson, PR
    [J]. LANCET, 2001, 357 (9260): : 960 - 960
  • [6] Cholesterol-lowering therapy - Response
    Matsuoka, H
    Tamai, O
    Imaizumi, T
    [J]. CIRCULATION, 1997, 96 (10) : 3801 - 3802
  • [7] Cholesterol-Lowering Gene Therapy Counteracts the Development of Non-ischemic Cardiomyopathy in Mice
    Muthuramu, Ilayaraja
    Amin, Ruhul
    Postnov, Andrey
    Mishra, Mudit
    Aboumsallem, Joseph Pierre
    Dresselaers, Tom
    Himmelreich, Uwe
    Van Veldhoven, Paul P.
    Gheysens, Olivier
    Jacobs, Frank
    De Geest, Bart
    [J]. MOLECULAR THERAPY, 2017, 25 (11) : 2513 - 2525
  • [8] Pharmacogenomics of cholesterol-lowering therapy
    Schmitz, G
    Langmann, T
    [J]. VASCULAR PHARMACOLOGY, 2006, 44 (02) : 75 - 89
  • [10] Cholesterol-lowering therapy in diabetic and elderly coronary artery disease patients
    Massing, MW
    Sueta, CA
    Simpson, RJ
    Chowdhury, M
    Biggs, DP
    [J]. CIRCULATION, 1999, 100 (18) : 103 - 103